Cargando…
Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
PURPOSE: Dry eye is a chronic inflammatory ocular surface disease with high prevalence. The current therapies for dry eye remain to be unspecific and notcomprehensive. This study aims to explore safety and efficacy of a novel treatment – subconjunctival injection of bevacizumab – in dry eye patients...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472070/ https://www.ncbi.nlm.nih.gov/pubmed/26109847 http://dx.doi.org/10.2147/DDDT.S85529 |